Dr. Rayaz Ahmed is a distinguished hematologist and bone marrow transplant expert with over 15 years of experience and more than 1000 successful bone marrow transplants to his credit. He is known for his expertise in complex stem cell transplants and in managing challenging blood disorders and cancers. Before joining Max Healthcare, he served as Associate Professor at CMC Vellore and Senior Consultant at Rajiv Gandhi Cancer Institute and Research Centre, New Delhi.
Educational Qualification:
- MBBS, Pt. Ravi Shanker University, Raipur, Chhattisgarh, India, 1999
- MD (Pathology), Shivaji University, Kolhapur, Maharashtra, 2003 (University Gold Medal)
- DM (Hematology), Christian Medical College & Hospital, Vellore, Tamil Nadu, 2010
Professional Experience:
- Senior Director, Cancer Care / Oncology, Bone Marrow Transplant, Hematology & Hematology Oncology, Max Healthcare (Max Hospital Saket Smart, Max Hospital Saket East, and Lajpat Nagar-MICC, New Delhi)
- Senior Consultant, Department of Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
- Associate Professor, Department of Hematology, Christian Medical College (CMC), Vellore
Awards and Achievements:
- Successfully Conducted Autologous, Allogeneic (MSD, MUD, Haplo)
- University Gold Medal in MD Pathology 2003, Shivaji University, Kolhapur, Maharashtra
Publication:
- Multiple research papers including:
- Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children
- Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study
- BRAF mutations in hairy cell leukaemia
- Fludarabine-based conditioning regimen in severe aplastic anemia – a retrospective analysis
- Novel missense mutations in transferrin causing hypochromic microcytic anaemia and haemosiderosis
- Outcome of low cost protocol in adults with T cell acute lymphoblastic leukemia
- Improved clinical outcomes of high risk thalassemia major patients with treosulfan-based conditioning regimen
- Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia
- Molecular basis of Wiskott-Aldrich syndrome in Indian patients
- Carbonyl reductase 1 expression and daunorubicin metabolism in acute myeloid leukemia